Secukinumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Secukinumab and local guidelines before prescribing.

Biologic (IL-17)

Mechanism

IL-17A monoclonal antibody.

Uses

Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infections, candidiasis, inflammatory bowel disease flares, diarrhoea.

Interactions

Live vaccines contraindicated.

Contraindications and cautions

Active infection, IBD

Monitoring

TB screen, infection

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Screen for TB; caution in IBD.

More from the textbook: uses, cautions and other points
Where it is discussed in the book